Neo-Recormon is a drug used for the treatment of symptomatic anaemia in patients with solid and lymphoid cancers receiving any form of chemotherapy and anaemia associated with chronic renal failure in patients on dialysis. It’s purpose is to increase the yield of autologous blood collection from patients in a pre-donation programme and to prevent anaemia in premature infants with birth weight between 750g to 1500g and with gestational age of less than 34 weeks.
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
